Publications by authors named "Sue A Yocum"

Claim this Profile
S
Similarities and discrepancies in subchondral bone structure in two differently induced canine models of osteoarthritis.
Femke Intema, Yvonne H Sniekers, Harrie Weinans, Marieke E Vianen, Sue A Yocum

J Bone Miner Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGFBP-5 Metabolism Is Disrupted in the Rat Medial Meniscal Tear Model of Osteoarthritis.
Matthew P Yates, Steven L Settle, Sue A Yocum, Poonam Aggarwal, Lillian E Vickery

Cartilage· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration.
Ralph P Robinson, Leonard Buckbinder, Amber I Haugeto, Patricia A McNiff, Michele L Millham, Sue A Yocum

J Med Chem· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.
Kevin D Freeman-Cook, Lawrence A Reiter, Mark C Noe, Amy S Antipas, Dennis E Danley, Sue A Yocum

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent, selective pyrimidinetrione-based inhibitors of MMP-13.
Lawrence A Reiter, Kevin D Freeman-Cook, Christopher S Jones, Gary J Martinelli, Amy S Antipas, Sue A Yocum

Bioorg Med Chem Lett· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.
Mark C Noe, Vijayalakshmi Natarajan, Sheri L Snow, Lilli A Wolf-Gouveia, Peter G Mitchell, Sue A Yocum

Bioorg Med Chem Lett· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.
Mark C Noe, Vijayalakshmi Natarajan, Sheri L Snow, Peter G Mitchell, Lori Lopresti-Morrow, Sue A Yocum

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.
Julian A Blagg, Mark C Noe, Lilli A Wolf-Gouveia, Lawrence A Reiter, Ellen R Laird, Sue A Yocum

Bioorg Med Chem Lett· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.
Mark C Noe, Sheri L Snow, Lilli A Wolf-Gouveia, Peter G Mitchell, Lori Lopresti-Morrow, Sue A Yocum

Bioorg Med Chem Lett· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.
Lawrence A Reiter, Ralph P Robinson, Kim F McClure, Christopher S Jones, Matthew R Reese, Sue A Yocum

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.
Lawrence A Reiter, Peter G Mitchell, Gary J Martinelli, Lori L Lopresti-Morrow, Sue A Yocum

Bioorg Med Chem Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis